Matches in Nanopublications for { <http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT> ?p ?o ?g. }
- OBJECT label "four randomized controlled trials ( RCTs , with another longer-term follow-up of one RCT ) and 63 observational studies" provenance.
- OBJECT label "four randomized controlled trials ( RCTs , with another longer-term follow-up of one RCT ) and 63 observational studies" provenance.
- OBJECT label "four randomized controlled trials ( RCTs , with another longer-term follow-up of one RCT ) and 63 observational studies" provenance.
- OBJECT label "four randomized controlled trials ( RCTs , with another longer-term follow-up of one RCT ) and 63 observational studies" provenance.
- OBJECT label "four randomized controlled trials ( RCTs , with another longer-term follow-up of one RCT ) and 63 observational studies" provenance.
- OBJECT label "four randomized controlled trials ( RCTs , with another longer-term follow-up of one RCT ) and 63 observational studies" provenance.
- OBJECT label "four randomized controlled trials ( RCTs , with another longer-term follow-up of one RCT ) and 63 observational studies" provenance.
- OBJECT label "four randomized controlled trials ( RCTs , with another longer-term follow-up of one RCT ) and 63 observational studies" provenance.
- OBJECT label "four randomized controlled trials ( RCTs , with another longer-term follow-up of one RCT ) and 63 observational studies" provenance.
- OBJECT label "four randomized controlled trials ( RCTs , with another longer-term follow-up of one RCT ) and 63 observational studies" provenance.
- OBJECT label "the effectiveness of DMARDs in Takayasu arteritis ( TAK" provenance.
- OBJECT label "the effectiveness of DMARDs in Takayasu arteritis ( TAK" provenance.
- OBJECT label "the effectiveness of DMARDs in Takayasu arteritis ( TAK" provenance.
- OBJECT label "the effectiveness of DMARDs in Takayasu arteritis ( TAK" provenance.
- OBJECT label "an evolving area" provenance.
- OBJECT label "an evolving area" provenance.
- OBJECT label "an evolving area" provenance.
- OBJECT label "an evolving area" provenance.
- OBJECT label "an evolving area" provenance.
- OBJECT label "with disease-modifying anti-rheumatic drugs ( DMARDs )" provenance.
- OBJECT label "with disease-modifying anti-rheumatic drugs ( DMARDs )" provenance.
- OBJECT label "with disease-modifying anti-rheumatic drugs ( DMARDs )" provenance.
- OBJECT label "anti-rheumatic drugs ( DMARDs )" provenance.
- OBJECT label "anti-rheumatic drugs ( DMARDs )" provenance.
- OBJECT label "anti-rheumatic drugs ( DMARDs )" provenance.
- OBJECT label "anti-rheumatic drugs ( DMARDs )" provenance.
- OBJECT label "for the treatment of Cytokine release syndrome ( CRS ) or cytokine storm in India" provenance.
- OBJECT label "for the treatment of Cytokine release syndrome ( CRS ) or cytokine storm in India" provenance.
- OBJECT label "for the treatment of Cytokine release syndrome ( CRS ) or cytokine storm in India" provenance.
- OBJECT label "for the treatment of Cytokine release syndrome ( CRS ) or cytokine storm in India" provenance.
- OBJECT label "for the treatment of Cytokine release syndrome ( CRS ) or cytokine storm in India" provenance.
- OBJECT label "for the treatment of Cytokine release syndrome ( CRS ) or cytokine storm in India" provenance.
- OBJECT label "for the treatment of Cytokine release syndrome ( CRS ) or cytokine storm in India" provenance.
- OBJECT label "for the treatment of Cytokine release syndrome ( CRS ) or cytokine storm in India" provenance.
- OBJECT label "Coronavirus disease 2019 mortality" provenance.
- OBJECT label "Coronavirus disease 2019 mortality" provenance.
- OBJECT label "Coronavirus disease 2019 mortality" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "for COVID-19 therapy" provenance.
- OBJECT label "antivirals like remdesivir , lopinavir , ritonavir , arbidol , oseltamivir , penciclovir , favipiravir , ganciclovir , and ribavirin ;" provenance.
- OBJECT label "antivirals like remdesivir , lopinavir , ritonavir , arbidol , oseltamivir , penciclovir , favipiravir , ganciclovir , and ribavirin ;" provenance.
- OBJECT label "antivirals like remdesivir , lopinavir , ritonavir , arbidol , oseltamivir , penciclovir , favipiravir , ganciclovir , and ribavirin ;" provenance.
- OBJECT label "antivirals like remdesivir , lopinavir , ritonavir , arbidol , oseltamivir , penciclovir , favipiravir , ganciclovir , and ribavirin ;" provenance.
- OBJECT label "antivirals like remdesivir , lopinavir , ritonavir , arbidol , oseltamivir , penciclovir , favipiravir , ganciclovir , and ribavirin ;" provenance.
- OBJECT label "antivirals like remdesivir , lopinavir , ritonavir , arbidol , oseltamivir , penciclovir , favipiravir , ganciclovir , and ribavirin ;" provenance.
- OBJECT label "antivirals like remdesivir , lopinavir , ritonavir , arbidol , oseltamivir , penciclovir , favipiravir , ganciclovir , and ribavirin ;" provenance.
- OBJECT label "antivirals like remdesivir , lopinavir , ritonavir , arbidol , oseltamivir , penciclovir , favipiravir , ganciclovir , and ribavirin ;" provenance.
- OBJECT label "antivirals like remdesivir , lopinavir , ritonavir , arbidol , oseltamivir , penciclovir , favipiravir , ganciclovir , and ribavirin ;" provenance.
- OBJECT label "antivirals like remdesivir , lopinavir , ritonavir , arbidol , oseltamivir , penciclovir , favipiravir , ganciclovir , and ribavirin ;" provenance.
- OBJECT label "in the event that dexamethasone is unavailable" provenance.
- OBJECT label "in the event that dexamethasone is unavailable" provenance.
- OBJECT label "in the event that dexamethasone is unavailable" provenance.
- OBJECT label "in the event that dexamethasone is unavailable" provenance.
- OBJECT label "unavailable" provenance.
- OBJECT label "in case of ARDS" provenance.
- OBJECT label "in case of ARDS" provenance.
- OBJECT label "in case of ARDS" provenance.
- OBJECT label "in case of ARDS" provenance.
- OBJECT label "dexamethasone , vitamin D , tocilizumab and sarilumab , chloroquine , hydroxychloroquine , azithromycin , adalimumab and tetrandrine ," provenance.
- OBJECT label "dexamethasone , vitamin D , tocilizumab and sarilumab , chloroquine , hydroxychloroquine , azithromycin , adalimumab and tetrandrine ," provenance.
- OBJECT label "dexamethasone , vitamin D , tocilizumab and sarilumab , chloroquine , hydroxychloroquine , azithromycin , adalimumab and tetrandrine ," provenance.
- OBJECT label "dexamethasone , vitamin D , tocilizumab and sarilumab , chloroquine , hydroxychloroquine , azithromycin , adalimumab and tetrandrine ," provenance.
- OBJECT label "dexamethasone , vitamin D , tocilizumab and sarilumab , chloroquine , hydroxychloroquine , azithromycin , adalimumab and tetrandrine ," provenance.
- OBJECT label "dexamethasone , vitamin D , tocilizumab and sarilumab , chloroquine , hydroxychloroquine , azithromycin , adalimumab and tetrandrine ," provenance.
- OBJECT label "dexamethasone , vitamin D , tocilizumab and sarilumab , chloroquine , hydroxychloroquine , azithromycin , adalimumab and tetrandrine ," provenance.
- OBJECT label "dexamethasone , vitamin D , tocilizumab and sarilumab , chloroquine , hydroxychloroquine , azithromycin , adalimumab and tetrandrine ," provenance.
- OBJECT label "in the treatment of COVID-19" provenance.
- OBJECT label "in the treatment of COVID-19" provenance.